Cardlytics (CDLX) to Release Earnings on Wednesday

Cardlytics (NASDAQ:CDLXGet Free Report) will likely be posting its quarterly earnings results after the market closes on Wednesday, March 12th. Analysts expect Cardlytics to post earnings of ($0.24) per share and revenue of $63.63 million for the quarter. Investors interested in registering for the company’s conference call can do so using this link.

Cardlytics Stock Performance

Shares of NASDAQ:CDLX opened at $2.00 on Monday. The company has a market capitalization of $101.64 million, a price-to-earnings ratio of -0.33 and a beta of 1.62. The firm’s 50 day simple moving average is $3.16 and its 200 day simple moving average is $3.55. The company has a debt-to-equity ratio of 2.40, a current ratio of 1.18 and a quick ratio of 1.18. Cardlytics has a fifty-two week low of $1.99 and a fifty-two week high of $20.52.

Analyst Ratings Changes

Separately, Needham & Company LLC reissued a “hold” rating on shares of Cardlytics in a report on Friday, January 17th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, Cardlytics presently has a consensus rating of “Hold” and an average price target of $6.92.

Get Our Latest Report on CDLX

Insider Transactions at Cardlytics

In related news, CEO Amit Gupta sold 15,160 shares of Cardlytics stock in a transaction that occurred on Friday, January 24th. The stock was sold at an average price of $3.92, for a total transaction of $59,427.20. Following the sale, the chief executive officer now directly owns 215,494 shares in the company, valued at $844,736.48. The trade was a 6.57 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CFO Alexis Desieno sold 24,778 shares of Cardlytics stock in a transaction that occurred on Tuesday, February 18th. The shares were sold at an average price of $3.40, for a total value of $84,245.20. Following the sale, the chief financial officer now owns 140,948 shares in the company, valued at $479,223.20. This represents a 14.95 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 111,454 shares of company stock worth $391,864. 4.40% of the stock is owned by company insiders.

Cardlytics Company Profile

(Get Free Report)

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.

Featured Stories

Earnings History for Cardlytics (NASDAQ:CDLX)

Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.